Global COVID-19 Drug Pipeline Scenario, 2020

Dublin, April 03, 2020 (GLOBE NEWSWIRE) — The “The COVID-19 Drug Pipeline 2020: Current Status, Phase, Companies, Pre-Clinical & Clinical Drugs” report has been added to ResearchAndMarkets.com’s offering. The 2020 COVID-19 pipeline report presents a comprehensive overview of the research and development of COVID drug candidates. It presents drugs […]

Click here to view original web page at www.globenewswire.com

Respiratory Syncytial Virus (RSV) Diagnostics Market Overview by Size, Value, Mega Trends, Global Players as Abbott, Roche, BD, Thermo Fisher, Luminex, Danaher, Biocartis, Hologic, BioMerieux, etc | Outlook to 2026 – WMR

RSV Diagnostics Respiratory Syncytial Virus (RSV) Diagnostics Market Survival Strategies explore Economic Impact in International Industries Manufactures, Growth, Size, Share, Trends, Development Challenges and Opportunities till 2026. The new research on Respiratory Syncytial Virus (RSV) Diagnostics gives a fundamental data and factually assessed information about the industry worldwide. The […]

Click here to view original web page at www.openpr.com

Open Orphan PLC Q&A: Coronavirus challenge study model (LON:ORPH)

Open Orphan PLC (LON:ORPH ) Chief Executive Officer Cathal Friel caught up with DirectorsTalk for an exclusive interview to discuss the world’s first human coronavirus challenge study model. Q1: We’ve just seen that you’ve begun the development of the world’s first commercial human coronavirus challenge study model. What can […]

Click here to view original web page at www.directorstalkinterviews.com

Black Monday How market panic can feed back to the world economy

FINANCIAL MARKETS have not endured a day as brutal as March 9th since the global financial crisis of 2007-09. Stockmarkets were a sea of red ink. The S&P 500 index fell by 7.6%. The FTSE 100—laden with oil firms, such as Shell and BP, and other natural-resource companies—suffered a […]

Click here to view original web page at www.economist.com

New hVIVO contract signed with a European Biotech Company

Initial study for the provision of a RSV human challenge study Respiratory Syncytial Virus (“RSV”) human challenge study Projected to deliver £3.2m in revenue in 2020 with the pivotal challenge study expected to commence end Q4 2020, with the potential to deliver significant further revenue expected to be a […]

Click here to view original web page at www.pharmiweb.com

Trinity Biotech latest coronavirus play, up 26%

Thinly traded nano cap Trinity Biotech plc ( TRIB +25.6%) is up on more than a 6x surge in volume, benefitting from the market’s enthusiasm for any company (potentially) related to the coronavirus outbreak. The Irish diagnostic test maker has not announced any formal plans for a coronavirus test, […]

Click here to view original web page at seekingalpha.com

Viroclinics Biosciences and DDL Diagnostic Laboratory Join Forces

Two leading virology testing laboratories integrate to form new group serving global biopharmaceutical industry ROTTERDAM, Netherlands, March 3, 2020 /PRNewswire/ — Viroclinics Biosciences, a leading virology contract research organization, announced today that it has acquired DDL Diagnostic Laboratory, a leading diagnostic solutions provider. The transaction enhances the combined group’s […]

Click here to view original web page at finance.yahoo.com

Global Drugs For Respiratory Syncytial Virus (Rsv) Market 2020 Growing Rapidly with Recent Developments, Industry Size, Share, Trends, Demand, Revenue, Key Findings and Latest Technology, Forecast Research Report 2026

Global “ Drugs For Respiratory Syncytial Virus (Rsv) ” Market Research Report 2020-2026 is a historical overview and in-depth study on the current & future market of the Drugs For Respiratory Syncytial Virus (Rsv) industry. The report represents a basic overview of the Drugs For Respiratory Syncytial Virus (Rsv) […]

Click here to view original web page at kpmnews.com

Money Talks – Covid-19 spreads—is a global economic downturn on the cards? | Podcasts | The Economist

Cash certainly does talk and the quicker that the uber rich realise this I guarantee a lot more money will flow into research. However, its worth noting that a substantial amount of that money needs to go to LMIC countries. MERS proves that trying to wait this out until the northern hemisphere season MAY reduce its impact could easily be a mistake...RLW

Avian Influenza Drug Market To Show Tremendous Growth By 2026|F. Hoffmann-La Roche Ltd, Allergan, BIOCRYST PHARMACEUTICALS, INC, PATH, Novartis AG, Baxter

Avian influenza drug market is rising gradually with a substantial CAGR in the forecast period of 2019-2026 Government policies and initiatives to offer a fund to many research institute and pharmaceuticals companies for developing novel therapy and adoption of poultry farming as occupation are the factors for increase in […]

Click here to view original web page at newsparent.com